Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 2, 2015, Pages 1803-1813

  Jia, Qingzhu ^a,b   Yang, Yi ^a,b   Wan, Ying ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Key Laboratory of Cytomics   (China)

Author keywords

Cancer; Memory T cells; Prognosis; Survival; Tumour infiltrating lymphocyte

Indexed keywords

CD45RO ANTIGEN;

ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; MEMORY T LYMPHOCYTE; META ANALYSIS; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

EID: 84926348609     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. [1] Nguyen TT, Wright JD, Powell MA, Gibb RK, Rader JS, Allsworth JE and Mutch DG. Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer. Int J Gynecol Cancer 2008; 18: 1194-1199.
2. [2] Winter WE 3rd, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F and McGuire WP. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007; 25: 3621-3627.
3. [3] Bindea G, Mlecnik B, Angell HK and Galon J. The immune landscape of human tumors: Implications for cancer immunotherapy. Oncoimmunology 2014; 3: e27456.
4. [4] Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, Jiang T and Wu A. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br J Cancer 2014; 110: 2560-2568.
5. [5] Halapi E, Yamamoto Y, Juhlin C, Jeddi-Tehrani M, Grunewald J, Andersson R, Hising C, Masucci G, Mellstedt H and Kiessling R. Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas. Cancer Immunol Immunother 1993; 36: 191-197.
6. [6] Hayashi K, Yonamine K, Masuko-Hongo K, Iida T, Yamamoto K, Nishioka K and Kato T. Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans. Gynecol Oncol 1999; 74: 86-92.
7. [7] Yamamoto Y, Backlin K, Nakagomi H, Halapi E, Juhlin C, Bucht A and Kiessling R. Cytotoxic activity and T cell receptor repertoire in tumor-infiltrating lymphocytes of adrenal cell carcinomas. Cancer Immunol Immunother 1993; 37: 163-168.
8. [8] Hiraoka N. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology. Int J Clin Oncol 2010; 15: 544-551.
9. [9] Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS and Ogino S. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 2010; 222: 350-366.
10. [10] Gooden MJ, de Bock GH, Leffers N, Daemen T and Nijman HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 2011; 105: 93-103.
11. [11] Hwang WT, Adams SF, Tahirovic E, Hagemann IS and Coukos G. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol 2012; 124: 192-198.
12. [12] Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH and Pages F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964.
13. [13] Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH and Galon J. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353: 2654-2666.
14. [14] Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL and Kim WH. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer 2008; 99: 1704-1711.
15. [15] Enomoto K, Sho M, Wakatsuki K, Takayama T, Matsumoto S, Nakamura S, Akahori T, Tanaka T, Migita K, Ito M and Nakajima Y. Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma. Clin Exp Immunol 2012; 168: 186-191.
16. [16] Rauser S, Langer R, Tschernitz S, Gais P, Jutting U, Feith M, Hofler H and Walch A. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma. BMC Cancer 2010; 10: 608.
17. [17] Hotta K, Sho M, Fujimoto K, Shimada K, Yamato I, Anai S, Konishi N, Hirao Y, Nonomura K and Nakajima Y. Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma. Br J Cancer 2011; 105: 1191-1196.
18. [18] de Jong RA, Leffers N, Boezen HM, ten Hoor KA, van der Zee AG, Hollema H and Nijman HW. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol 2009; 114: 105-110.
19. [19] Gao Q, Zhou J, Wang XY, Qiu SJ, Song K, Huang XW, Sun J, Shi YH, Li BZ, Xiao YS and Fan J. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Ann Surg Oncol 2012; 19: 455-466.
20. [20] Lee WS, Park S, Lee WY, Yun SH and Chun HK. Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer. Cancer 2010; 116: 5188-5199.
21. [21] Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, ten Hoor KA, Hollema H, Boezen HM, van der Zee AG, Daemen T and Nijman HW. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother 2009; 58: 449-459.
22. [22] Oberg A, Samii S, Stenling R and Lindmark G. Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int J Colorectal Dis 2002; 17: 25-29.
23. [23] Pages F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, Berger A, Fridman WH and Galon J. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 2009; 27: 5944-5951.
24. [24] Peng RQ, Chen YB, Ding Y, Zhang R, Zhang X, Yu XJ, Zhou ZW, Zeng YX and Zhang XS. Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer. World J Gastroenterol 2010; 16: 2428-2434.
25. [25] Peng RQ, Wu XJ, Ding Y, Li CY, Yu XJ, Zhang X, Pan ZZ, Wan DS, Zheng LM, Zeng YX and Zhang XS. Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer. BMC Cancer 2010; 10: 496.
26. [26] Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C and Iacopetta B. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009; 27: 186-192.
27. [27] Wakatsuki K, Sho M, Yamato I, Takayama T, Matsumoto S, Tanaka T, Migita K, Ito M, Hotta K and Nakajima Y. Clinical impact of tumor-infiltrating CD45RO(+) memory T cells on human gastric cancer. Oncol Rep 2013; 29: 1756-1762.
28. [28] Kandalaft LE, Singh N, Liao JB, Facciabene A, Berek JS, Powell DJ Jr and Coukos G. The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade. Gynecol Oncol 2010; 116: 222-233.
29. [29] Dunn GP, Old LJ and Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22: 329-360.
30. [30] Cauley LS and Lefrancois L. Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol 2013; 6: 14-23.
31. [31] Masopust D, Choo D, Vezys V, Wherry EJ, Duraiswamy J, Akondy R, Wang J, Casey KA, Barber DL, Kawamura KS, Fraser KA, Webby RJ, Brinkmann V, Butcher EC, Newell KA and Ahmed R. Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Med 2010; 207: 553-564.
32. [32] Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK, Lucas PJ, Artis D, Wherry EJ, Hogquist K, Vezys V and Masopust D. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Immunol 2012; 188: 4866-4875.
33. [33] Masopust D, Vezys V, Wherry EJ, Barber DL and Ahmed R. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J Immunol 2006; 176: 2079-2083.
34. [34] Isakov D, Dzutsev A, Belyakov IM and Berzofsky JA. Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alpha-beta(+) T cells in the small intestinal mucosa. Mucosal Immunol 2009; 2: 450-461.